Aleva Neurotherapeutics: Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM Directional Deep Brain Stimulation System

(marketscreener.com) - First system implanted at University Hospital of Dresden / Prof. Sobottka - Post-market clinical follow-up and revenue-generating study in the EU - Targeting US FDA IDE approval in Q4, 2021 Lausanne, Switzerland, June 17, 2021 - Aleva Neurotherapeutics, a leading developer of implants for deep brain stimulation in major...https://www.marketscreener.com/news/latest/Aleva-Neurotherapeutics-Recruits-First-Patient-into-its-PMCF-Study-with-its-directSTIM-trade-Direct--35629521/?utm_medium=RSS&utm_content=20210617